Publications by authors named "Seth Toback"

Claim this Profile
T
The shadow of reactogenicity: Parental hesitancy due to prior vaccine experiences.
Manuela H Gschwend, Emmanuel Faust, Matthew D Rousculp, Seth Toback

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local and systemic reactogenicity after mRNA and protein-based COVID-19 vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomized phase 2 trial (COV-BOOST).
Anthony M Marchese, Hadi Beyhaghi, Matthew D Rousculp, Vivian Huang, Xinxue Liu, Seth Toback

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.
Anthony M Marchese, Matthew Rousculp, John Macbeth, Hadi Beyhaghi, Bruce T Seet, Seth Toback

J Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines.
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Seth Toback

Vaccines (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.
Seth Toback, Anthony M Marchese, Brandy Warren, Sondos Ayman, Senka Zarkovic

Vaccine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study.
Matthew D Rousculp, Kelly Hollis, Ryan Ziemiecki, Dawn Odom, Anthony M Marchese, Seth Toback

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines.
Anthony M Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback

Expert Rev Vaccines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine.
Eddie Underwood, Lisa M Dunkle, Shabir A Madhi, Cynthia L Gay, Paul T Heath, Seth Toback

Expert Rev Vaccines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial.
Anthony M Marchese, Xiang Zhou, John Kinol, Eddie Underwood, Wayne Woo, Seth Toback

Vaccine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Paul T Heath, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Seth Toback

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
Seth Toback, Eva Galiza, Catherine Cosgrove, James Galloway, Anna L Goodman

Lancet Respir Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation.
Luca Molinari, Fabienne Heskia, Sadudee Peerapornratana, Claudio Ronco, Louis Guzzi, Seth Toback

Crit Care Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States.
Stephanie Earnshaw, Hadi Beyhaghi, Cheryl McDade, Molly Purser, Robert Marriott, Seth Toback

Transfusion· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
Paul T Heath, Eva P Galiza, David N Baxter, Marta Boffito, Duncan Browne, Seth Toback

N Engl J Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs.
Vladislav Pavlov, Philippe Thompson-Leduc, Louise Zimmer, Jody Wen, Jerome Shea, Seth Toback

Brain Inj· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Midturbinate Swabs Are Comparable to Nasopharyngeal Swabs for Quantitative Detection of Respiratory Syncytial Virus in Infants.
Anne J Blaschke, Matt McKevitt, Krow Ampofo, Tammi Lewis, Hao Chai, Seth Toback

J Pediatric Infect Dis Soc· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker.
Mauricio A Berdugo, Noam Y Kirson, Louise Zimmer, Hadi Beyhaghi, Seth Toback

J Med Econ· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric evaluation of a caregiver diary for the assessment of symptoms of respiratory syncytial virus.
Valerie Williams, Carla DeMuro, Sandy Lewis, Nicole Williams, Todd Wolynn, Seth Toback

J Patient Rep Outcomes· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials.
Sandy Lewis, Carla DeMuro, Stan L Block, Shelly Senders, Paul Wisman, Seth Toback

J Patient Rep Outcomes· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral GS-5806 activity in a respiratory syncytial virus challenge study.
John P DeVincenzo, Richard J Whitley, Richard L Mackman, Cecilia Scaglioni-Weinlich, Lisa Harrison, Seth L Toback

N Engl J Med· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Section on advances in therapeutics and technology.
Charles A Thompson, Seth Toback

Clin Ther· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with in-office influenza vaccination by U.S. pediatric providers.
Chyongchiou Jeng Lin, Mary Patricia Nowalk, Seth L Toback, Christopher S Ambrose

BMC Pediatr· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children.
Terho Heikkinen, Stan L Block, Seth L Toback, Xionghua Wu, Christopher S Ambrose

Pediatr Infect Dis J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
Seth L Toback, Christopher S Ambrose, Abigail Eaton, John Hansen, Laurie Aukes

Vaccine· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved timing of availability and administration of influenza vaccine through the US Vaccines for Children Program from 2007 to 2011.
Christopher S Ambrose, Seth L Toback

Clin Pediatr (Phila)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis